Analyst Joe Laetsch raises HF Sinclair's price target, highlighting favorable crude differentials and a recent $38 million acquisition aimed at expanding its lubricants business, as the refiner lands on a list of top low-risk dividend stocks.
Columbia Financial (NASDAQ: CLBK) has announced a definitive agreement to merge with Northfield Bancorp in an all-stock transaction valued at approximately $597 million. The deal, slated to close in early Q3 2026, coincides with Columbia's planned "second-step" conversion to a fully public company, a move executives say will unlock value and create a leading regional bank in the New Jersey-New York metro area.
Shares of Columbia Financial (CLBK) rallied sharply after the community bank announced a definitive agreement to acquire Northfield Bancorp, a move set to create New Jersey's third-largest regional bank and significantly boost future earnings.
President Gustavo Petro's suggestion that Jesus Christ had a romantic relationship with Mary Magdalene has drawn sharp criticism from religious groups and believers, igniting a heated debate about the boundaries between political speech and religious respect in the predominantly Christian nation.
A sweeping federal mandate now requires leak monitoring and repair for appliances containing as little as 15 pounds of HFCs, significantly lowering the previous threshold and placing new operational burdens on countless facilities.
ABB's shares surged 10% following its annual results, with earnings per share exceeding forecasts. Analysts have raised their price target to CHF 60.30 and project accelerated revenue growth ahead of industry peers.
Shareholder analysis reveals a distinctive ownership structure at Swiss electrical engineering group Burkhalter Holding, where retail investors collectively hold the largest stake, while insiders retain significant control. This balance of power highlights both broad public interest and strong managerial alignment in the CHF1.5 billion company.
The death of Alicia Harnishfeger, discovered under a downtown bridge during a severe cold snap, has sparked conversations about systemic failures in addressing homelessness intertwined with mental health and substance abuse crises.
A captive breeding program for the elusive Guthega skink in Victoria's high country yields a rare pregnancy, potentially boosting the known wild population from 11 to 13 individuals.
While many AI stocks soared in 2025, Salesforce shares faced significant headwinds. Despite a challenging year, the cloud software giant's robust fundamentals and reasonable valuation suggest it may be poised for a recovery.
The Priestly Society of St. Pius X (SSPX) announced plans to consecrate new bishops in July without Vatican approval, escalating a decades-long doctrinal standoff and prompting concerns of a permanent rupture within the Catholic Church.
Despite near-term headwinds in the electric vehicle sector, Rivian and BYD are positioning themselves for the next growth cycle through strategic pivots and vertical integration.
IAMGOLD (TSX:IMG) has reignited drilling at its Anik joint venture in Québec and issued updated production guidance, signaling accelerating operational momentum. The moves come as the gold miner's shares, despite recent volatility, have delivered staggering multi-year returns, highlighting a potential valuation gap.
Forensic genealogy has finally put a name to remains discovered in 2012, closing a long-standing mystery for Illinois authorities and a family.
In a revealing interview, former NFL quarterback Tim Tebow recounts how coach Bill Belichick asked him to decline a seven-figure endorsement deal—only to be cut days later. Yet, a decade on, Tebow expresses admiration, not bitterness, toward the legendary coach.
The Adecco Group is making a strategic pivot into higher-margin HR and talent consulting through its LHH brand, a move analysts say could reshape its valuation narrative amid a challenging stock performance history.
Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.
Zions Bancorporation has authorized a new $75 million stock repurchase program, a move analysts see as a bet on its undervalued shares and a commitment to shareholder returns as regional banks navigate a cautious regulatory environment.
New home listings in the San Antonio metro area fell sharply in December, the steepest decline among major U.S. cities, as a growing imbalance between sellers and buyers prompts homeowners to stay put.
Schweiter Technologies (SWTQ) has seen significant price swings on the SIX Swiss Exchange. With its current valuation trading well above industry peers, we examine whether the stock's optimistic growth prospects justify the premium or if investors should wait for a better entry point.
